Antiviral

All articles by Antiviral

Gilead inks $100M partnership with Assembly Bio for antivirals

Lecia Bushak

October 17, 2023

3:26 pm

Gilead will pay $100 million upfront for the deal, which will involve developing therapies for herpes simplex virus and hepatitis B virus.

From Our Partners

Partner Content

Medlive ENGAGE — Transform your digital peer-to-peer HCP education

Discover how Medlive ENGAGE connects pharmaceutical and biotech brands with healthcare providers through tailored video content and advanced engagement tools. Drive impactful education, boost audience interaction and achieve measurable success in delivering peer-to-peer learning experiences that resonate with your target professionals.

Partner Content

10 years of ‘Be Kind, Don’t Suck’ in PR and digital marketing

Listen as CEO/founder of EvolveMKD, Megan Driscoll, reflects on the last decade of change, founding and owning an agency during this time and what lessons she’s taken away for her company and on behalf of her clients.

Partner Content

Privacy matters: Marketing compliance in practice

How healthcare marketers approach patient privacy concerns.

Partner Content

Branding and awareness in a performance-driven landscape

In this episode, we dive into the evolving landscape of media strategy, with a special focus on brands with modest- to mid-tier budgets ($5-$50MM).

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Antiviral

All articles by Antiviral

Gilead inks $100M partnership with Assembly Bio for antivirals

MM+M Media Summit

From Our Partners

Partner Content

Medlive ENGAGE — Transform your digital peer-to-peer HCP education

Partner Content

10 years of ‘Be Kind, Don’t Suck’ in PR and digital marketing

Partner Content

Privacy matters: Marketing compliance in practice

Partner Content

Branding and awareness in a performance-driven landscape